Clinical Trial Update: Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether adding neoadjuvant chemotherapy to surgery improves outcomes for high-risk retroperitoneal sarcoma, and is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma
• Retroperitoneal Sarcoma

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Retroperitoneal Sarcoma, Liposarcoma | Phase 3 | Status: RECRUITING